Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis

by Britta Lundström-Stadelmann, Reto Rufener, Andrew Hemphill
Published 2020-08-01

The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis

by Britta Lundström-Stadelmann, Reto Rufener, Dominic Ritler, Raphael Zurbriggen, Andrew Hemphill
Published 2019-06-01

Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.

by Britta Stadelmann, Reto Rufener, Denise Aeschbacher, Markus Spiliotis, Bruno Gottstein, Andrew Hemphill
Published 2016-03-01

Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds.

by Dominic Ritler, Reto Rufener, Heinz Sager, Jacques Bouvier, Andrew Hemphill, Britta Lundström-Stadelmann
Published 2017-05-01

Author Correction: In vitro metabolomic footprint of the Echinococcus multilocularis metacestode

by Dominic Ritler, Reto Rufener, Jia V. Li, Urs Kämpfer, Joachim Müller, Claudia Bühr, Stefan Schürch, Britta Lundström-Stadelmann
Published 2021-02-01

Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis

by Reto Rufener, Luca Dick, Laura D'Ascoli, Dominic Ritler, Amani Hizem, Timothy N.C. Wells, Andrew Hemphill, Britta Lundström-Stadelmann
Published 2018-12-01

Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis

by Reto Rufener, Dominic Ritler, Jana Zielinski, Luca Dick, Emerson Teixeira da Silva, Adriele da Silva Araujo, Deborah Elisabeth Joekel, David Czock, Christine Goepfert, Adriana Marques Moraes, Marcus Vinicius Nora de Souza, Joachim Müller, Meike Mevissen, Andrew Hemphill, Britta Lundström-Stadelmann
Published 2018-08-01